We want to see if regulating GSK3β activity could weaken cystic TDP-43 intermediate neuroinflammatory in degenerative diseases.
No takes yet. Share an insight, caveat, or question.
Eu Jene Choi (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: